epacadostat plus pembrolizumab in patients with scchn: preliminary results from echo-202/keynote-037
Published 7 years ago • 467 plays • Length 7:16Download video MP4
Download video MP3
Similar videos
-
1:50
dr. hamid on epacadostat plus pembrolizumab in advanced melanoma
-
4:03
keynote-040: groundbreaking results for pembrolizumab in head and neck cancer
-
4:46
preliminary results from keynote-055: pembrolizumab in hnscc
-
0:54
neon-1 & neon-2: alpn-202 alone or with pembrolizumab in patients with advanced malignancies
-
1:35
dr. lara on epacadostat plus pembrolizumab in rcc
-
5:00
keynote-055:pembrolizumab in hnscc
-
2:45
final keynote-048 results with frontline pembrolizumab in recurrent/metastatic hnscc
-
4:43
metastatic squamous cell carcinoma survivor - erika's envita review
-
6:26
oct-guided laser treatment of basal cell carcinoma
-
3:04
head and neck cancer at asco 2022
-
1:39
pembrolizumab and epacadostat for nsclc: echo-306/keynote-715
-
2:23
pembrolizumab plus chemotherapy for esophageal cancer: keynote-590
-
1:00
adjuvant pembrolizumab in kidney cancer from keynote 564
-
1:13
keynote-b84: pepinemab pembrolizumab for metastatic/recurrent head & neck squamous cell carcinoma
-
2:22
keynote-057: extended follow-up of pembrolizumab in bladder cancer
-
3:03
adjuvant pembrolizumab improves rcc disease-free survival | toni choueiri
-
1:28
keynote-b61: first-line lenvatinib pembrolizumab in non-clear cell rcc
-
1:56
eftilagimod alpha and pembrolizumab in patients with squamous head and neck carcinoma
-
3:26
phase ii trial of pembro & epacadostat in patients with recurrent clear cell carcinoma of the ovary
-
2:22
adjuvant pembrolizumab and survival in renal-cell carcinoma | nejm
-
2:00
exploring the combination of epacadostat and pembrolizumab in urothelial carcinoma